Papers
6
Total Citations
88
H-Index
5
About
Jelena Ochs is a pioneering researcher at the forefront of automating regenerative medicine, specializing in the robotic manufacture of cell therapy products. Her work addresses a critical bottleneck in the field: transitioning the production of Advanced Therapy Medicinal Products (ATMPs) from costly, manual processes to scalable, clinically-compliant automation. Ochs’s major contributions include the development of the AUTOSTEM robotic platform, a closed, scalable system for producing clinical-grade mesenchymal stromal cells (MSCs) that has garnered 24 citations. She further advanced the field with the StemCellDiscovery platform, which integrates deep learning-based confluence estimation for high-throughput cell production, demonstrating a unique fusion of robotics and artificial intelligence. Her “needle to needle” concept for robot-assisted manufacture represents a holistic approach to cell therapy production, from tissue extraction to final product. With a portfolio of highly cited papers, including work on automated tissue dissociation and mass production design for Phase II clinical trials, Ochs is a key figure in making personalized cell therapies cost-effective and widely accessible, driving the future of regenerative medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6Automated Tissue Dissociation for Rapid Extraction of Viable Cells5 citations · 2017